All the latest worldwide HIV and AIDS news, including treatment, prevention, and hepatitis and TB co-infections. News from our own team of writers plus articles we have selected from other sources.

aidsmap hiv & aids news


hiv & aids news selected from other sources

  • Policy
    Preparing President Obama for the International AIDS Conference, July 2012
    Huffington Post | 23 March 2012

    We must urgently consider what preparations the U.S. needs to make for this global stage. Here, I focus on issues related to HIV in the U.S. because the conference traditionally spotlights the epidemic in the host country. We have serious policy and programmatic work to do to get our house in order before the world comes to our door.

  • Pharmaceutical industry
    Abbott Selects AbbVie as New Name for Future Research-Based Pharmaceutical Company
    Abbott press release | 23 March 2012

    Abbott today announced that AbbVie [pronounced Abb-vee] will be the name of the new, independent research-based pharmaceutical company it expects to launch by the end of 2012.

  • Access to medicines and treatment
    World Bank Report on Fiscal Constraints - A return of the 90's
    EATG / Health GAP | 23 March 2012

    The World Bank has just recently issued a "new" report: "The fiscal dimension of HIV/AIDS in Botswana, South Africa, Swaziland, and Uganda." The Report doesn't really feel "new" because it represents a recurrent theme in World Bank ideology from the earliest days of the global AIDS pandemic – it's not fiscally sustainable to treat people living with HIV in high impact, low-resource countries – instead the world must focus on "prevention." The World Bank is seriously out-of-date, or conversely, perversely pig-headed, for three main reasons.

  • Access to medicines and treatment
    Brazil HIV Drug Patent Ruling Allows Generics, Sends Pipeline Process Into Doubt
    Intellectual Property Watch | 23 March 2012

    Word is spreading of a recent decision by a Brazilian judge to annul a patent on a key AIDS drug, effectively allowing less expensive generic versions into the country, and calling into question other such patents.

  • Sex workers
    Sex work in New South Wales: healthiest in the world
    University of New South Wales press release | 23 March 2012

    The decriminalisation of sex work in NSW – combined with a free market approach – has resulted in one of the healthiest sex industries ever documented, a report to NSW Health has found.

  • UK health services
    London HIV drug tendering exercise: implementation explained
    Sexually Transmitted Infections | 23 March 2012

    London health commissioners and physiciansdescribe how collaboration in antiretroviral procurement in 2011/2012 aimed to significantly reduce drug acquisition costs, ensure equity of prescribing and protect the quality and experience of care and treatment for patients.

  • Tuberculosis and HIV
    Tuberculosis rises 8% in London - HPA figures
    BBC | 23 March 2012

    The Health Protection Agency (HPA) said there were 3,588 new cases in the capital in 2011 - up from 3,309 the year before. The rise is thought to be connected to a rise in homelessness in the city.Nationally TB increased by 5%.

  • New and experimental HIV treatments
    Avexa closer to EMA approval for ATC
    Australian Life Scientist | 23 March 2012

    Avexa Limited (ASX:AVX) and the EMA have agreed on the path forward to gaining European approval for drug-resistant HIV treatment ATC.

  • Health monitoring in resource-limited settings
    Origami paper device can test for HIV and malaria
    The Daily Texan | 23 March 2012

    Chemistry professor Richard Crooks and chemistry graduate student Hong Liu developed an origami Paper Analytical Device, or oPAD, that chemically analyzes human bodily fluids and identifies different biomarkers that signal the presence of disease. The device works with folded paper to run complex tests using less surface area and costs under 10 cents.

  • Cancer
    Electrocauterization Has Fewer Side Effects, Better Efficacy, Than Topical Treatments for Anal Lesions
    AIDSMeds | 23 March 2012

    When it comes to treating precancerous anal lesions, electrocauterization is both more effective and, somewhat surprisingly, better tolerated than repeated topical applications of either Aldara (imiquimod) or Efudex (fluorouracil), according to data presented Thursday, March 8, at the 19th Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle. 

Hepatitis C news

WHO recommends global use of newest hepatitis C drugs, urges price reductions.

HIV update

Sign up for HIV update, our fortnightly news bulletin for people living with HIV in the UK.

Treatment as prevention

No-one with an undetectable viral load, gay or heterosexual, transmits HIV in two years of PARTNER study.

aidsmap news apps

Download the free aidsmap news iPhone and android apps.